NextPlat Corp (NXPLW) Stock Analysis

Company Overview

NextPlat Corp operates as a diversified entity providing services within the healthcare and e-commerce sectors across Europe, North America, South America, Asia and the Pacific, and Africa. The company executes its strategy through two primary segments, specifically e-Commerce Operations and Healthcare Operations, which include the management of full-service retail and specialty services pharmacies. The firm's operational scale is defined by a market capitalization that is not disclosed in public filings, alongside an annual trailing twelve-month revenue of $57.15M and an employee base of 162 individuals. The absence of a disclosed market cap figure prevents a direct comparison with larger peers, while the revenue of $57.15M combined with a workforce of 162 suggests a mid-sized operational footprint focused on niche retail and pharmacy services rather than broad-scale industrial manufacturing.

Financial Health

The company reported a trailing twelve-month revenue of $57.15M, yet this top-line figure masks a net income loss of $-8,334,000 and an EBITDA of $-7,454,000. The significant disparity between the positive revenue of $57.15M and the substantial negative net income of $-8,334,000 reveals a cost structure where operating expenses heavily outweigh gross profits, indicating high burn rates or significant overhead costs relative to sales volume. Free cash flow stands at $-2,746,000, which indicates that the company is consuming cash from its operations and does not currently possess the liquidity generated internally to fund expansion without external financing. Gross margin is reported at 19.3%, suggesting that the company retains a moderate portion of revenue after direct costs, while the operating margin of -14.5% and profit margin of -14.6% confirm that fixed costs and inefficiencies are eroding profitability across the organization. On the balance sheet, the company holds $13.93M in cash against $1.72M in debt, supported by a debt-to-equity ratio of 7.96, which implies a highly leveraged capital structure despite the net cash position on the face of the balance sheet. The current ratio of 3.56 indicates that the company holds significantly more current assets than current liabilities, suggesting a theoretically strong short-term liquidity position to meet obligations as they come due. However, the return on equity of -32.5% and return on assets of -14.4% reveal that management is currently destroying shareholder value and utilizing assets inefficiently, as these negative return metrics indicate that the company's operations are failing to generate returns sufficient to cover the cost of capital.

Valuation Assessment

Trailing P/E and forward P/E ratios are both unavailable due to the negative earnings profile of the company, meaning traditional earnings-based valuation metrics cannot be applied to assess the price relative to profitability. The price-to-book ratio is 0.04, which indicates that the market is valuing the company at a fraction of its book value, suggesting a severe discount or potential distress rather than a market premium over tangible assets. Price-to-sales and EV/EBITDA metrics are also unavailable, preventing the use of revenue or cash-flow based multiples to gauge valuation relative to peers. The stock has a 52-week high of $0.04 and a 52-week low of $0.04, indicating that the current price is trading at 0% below the 52-week high and 0% above the 52-week low, effectively meaning the price has remained static or fluctuated within a negligible range during the year. The beta value is 1.27, which means the stock exhibits 27% higher volatility than the broader market, making it a riskier investment for those seeking stability relative to the overall market index.

Growth & Income

Revenue growth year-over-year stands at -10.5%, while earnings growth is unavailable due to the company's negative earnings history, preventing a direct comparison of earnings trajectory relative to revenue expansion. The absence of positive earnings growth data implies that the company is still in a phase of contraction or restructuring rather than scaling profitable operations. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio, indicating that it retains all available cash to fund operations or repay debt rather than returning capital to shareholders. The overall growth and income profile is characterized by revenue contraction of -10.5% and a complete lack of dividend income, reflecting a business model currently focused on survival and cost management rather than capital growth or income generation.